Management of fusariosis in transplant patients
Despite its rarity, fusariosis poses a disproportionate threat to transplant recipients due to diagnostic delays, lack of randomized trials, and few effective antifungal options. Incorporating rapid molecular diagnostics, next-generation antifungals, and immune-directed strategies will be critical to improving real-world outcomes and survival.
Authors
- Márcio Nucci (ORCID: https://orcid.org/0000-0003-4867-0014)
- Larissa Simão Gandolpho
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Nove de Julho (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Expert Review of Anti-infective Therapy
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/14787210.2026.2624618
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00